Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 308 N Main St, Cynthiana, KY 41031 Phone: 859-234-1424 Fax: 859-234-5463 |
Dr. Jeremy Vanloring Smith, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 202 W Pleasant St, Cynthiana, KY 41031 Phone: 859-234-1424 |
Dr. Allison L Harmon, OD Optometrist Medicare: Medicare Enrolled Practice Location: 308 N Main St, Cynthiana, KY 41031 Phone: 859-234-1424 |
Brett A Hines, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 308 N Main St, Cynthiana, KY 41031 Phone: 859-234-1424 Fax: 859-234-5463 |
Dr. Jeremy Lee Penn, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 308 N Main St, Cynthiana, KY 41031 Phone: 859-234-1424 Fax: 859-234-5463 |
Cynthiana Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 308 N Main St, Cynthiana, KY 41031 Phone: 859-234-1424 Fax: 859-234-5463 |
News Archive
Broadlane, the leading end-to-end cost-management partner for healthcare providers, announced today that New Hanover Regional Medical Center, in Wilmington, North Carolina, has renewed its supply chain relationship with Broadlane for another five years. New Hanover will continue to access Broadlane's unparalleled national contract portfolio of consumable supplies, equipment, pharmaceuticals and purchased services to help manage approximately $130 million in annual supply spend.
Informing how COVID-19 response plans may incorporate digital contact tracing, a model of COVID-19 spread within a simulated French population found that if about 20% of the population adopted a contact tracing app on their smartphones, an outbreak could be reduced by about 35%. If more than 30% of the population adopted the app, the epidemic could be suppressed to manageable levels.
One-fifth of all patients with pulmonary arterial hypertension suffer with the fatal disease for more than two years before being correctly diagnosed and properly treated, according to a new national study led by researchers at Intermountain Medical Center in Salt Lake City.
Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has been performed in the United States under the company's May 8th, 2015 FDA approval for commercial use of the Senza spinal cord stimulation (SCS) system, which delivers Nevro's proprietary HF10 therapy.
› Verified 3 days ago